Here’s why I’d buy these FTSE 250 stocks near 52-week lows

Could now be great time to buy into some underpriced FTSE 250 stocks ahead of the next mid-cap bull run? I think it just might.

| More on:

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I have good feelings about the FTSE 250, as the mid-cap index typically climbs ahead of the FTSE 100 when the market’s in a bullish mood.

The bulls aren’t exactly running right now, I know. But as inflation data improves and interest rates come down further, I reckon the chances of a new surge could grow by the day.

Biotech resurgence?

And that’s when I think stocks like PureTech Health (LSE: PRTC) could start to shine once more.

This is a biotech business. And at the end of the last full year, the firm spoke of its “broad and deep pipeline”, and reminded us that it has as many as “29 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval”.

PureTech stock’s had a bad year, as the appetite for smaller-cap growth stocks has faded. The new dip that kicked off in June hasn’t pushed the stock down quite as far as the 52-week low it set in December 2023. But we’re not far above it.

The road to profit

The key risk, as with so many similar stocks to this, is that there’s no profit yet. But forecasts at least see revenue starting to ramp up in 2025. And there seems to be plenty of cash on the books. As of December 2023, the company had “cash equivalents and short-term investments of $326m”.

As the economic clouds clear and investors are drawn back in to the stock market, I think we might see renewed growth stock sentiment. I’m very tempted to take the risk and go in with a small amount of cash. First-half results are due on 28 August.

Grounded airline

I don’t usually buy airline stocks. But Wizz Air’s (LSE: WIZZ) tanked in the past month, and it’s only slightly back up from its 52-week low.

In this case, the drop’s all down to Q1 earnings released on 1 August. The company revealed a crushing 98% fall in net profit, to just €1.2m.

CEO József Váradi spoke of “the resilience of Wizz Air’s ultra-low-cost business model.” I’m not entirely sure how such a huge profit fall can be a sign of anything positive, mind.

On the deck

Still, the problem looks to me to be a fairly short-term one. It’s all about plane groundings due to issues with the firm’s Pratt & Whitney GTF engines. At Q1 results time, the airline had 46 of its 179 aircraft firmly stuck on the ground. There’s going to be some compensation, which will help.

There’s intense competition in this business. And Wizz’s coming under pricing pressure, which I think it might have a bit of a struggle with.

But it still looks oversold to me. And this is another FTSE 250 stock I might buy a bit of when I have my next lot of investment cash ready.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are these 2 value stocks no-brainer buys, or ones to avoid?

These value stocks have caught our writer’s eye but is there more to them than a low valuation? This Fool…

Read more »

Investing Articles

If I invest £5,000 in Airtel Africa, how much passive income would I get?

Dividend shares are a great way of building passive income, so how much could this Fool expect to receive with…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

Is now the time for me to buy Palantir as the red-hot AI stock joins the S&P 500?

Shares of this unorthodox AI company have more than doubled over the past year. Is it time I added the…

Read more »

A front-view shot of a multi-ethnic family with two children walking down a city street on a cold December night.
Investing Articles

If I’d invested £20k in these 5 shares a year ago, this is how much passive income I’d have now

Dividend shares can be an excellent way to earn passive income. Our writer assesses his top dividend picks, past and…

Read more »

Investing For Beginners

2 UK shares down over 40% in a year that I think are worth buying

Jon Smith reviews two UK shares from the FTSE 250 he believes have suffered an overreaction in the recent share…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

These FTSE 100 stocks have taken a beating in 2024! But will they recover?

Despite the FTSE 100 rising by over 7% this year, these two stocks have suffered. Could now be a smart…

Read more »

Investing Articles

The Rolls-Royce share price looks great, but is this company is better value?

The Rolls-Royce share price has been flying in recent years, but with plenty of competition in the sector, is another…

Read more »

The Troat Inn on River Cherwell in Oxford. England
Investing Articles

Fevertree shares are down 80% in the FTSE AIM 100! Should I buy them for my ISA?

Shares of leading mixers maker Fevertree slumped 11% today, leaving this Fool wondering if this might be a golden chance…

Read more »